Lukas Scheibler
2018
In 2018, Lukas Scheibler earned a total compensation of $3.6M as Chief Innovation Officer at Apellis Pharmaceuticals.
Compensation breakdown
| Bonus | $114,843 |
|---|---|
| Option Awards | $3,265,000 |
| Salary | $250,000 |
| Other | $7,228 |
| Total | $3,637,071 |
Scheibler received $3.3M in option awards, accounting for 90% of the total pay in 2018.
Scheibler also received $114.8K in bonus, $250K in salary and $7.2K in other compensation.
Rankings
In 2018, Lukas Scheibler's compensation ranked 3,114th out of 14,244 executives tracked by ExecPay. In other words, Scheibler earned more than 78.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,114 out of 14,244 | 78th |
Division Manufacturing | 1,156 out of 5,765 | 80th |
Major group Chemicals And Allied Products | 401 out of 2,128 | 81st |
Industry group Drugs | 330 out of 1,817 | 82nd |
Industry Pharmaceutical Preparations | 253 out of 1,391 | 82nd |
Source: SEC filing on April 30, 2019.
Scheibler's colleagues
We found four more compensation records of executives who worked with Lukas Scheibler at Apellis Pharmaceuticals in 2018.